PM Capital Asian Opportunities Fund Ltd (ASX:PAF) to Issue $0.02 Final Dividend

Share on StockTwits

PM Capital Asian Opportunities Fund Ltd (ASX:PAF) declared a final dividend on Friday, August 23rd, MarketIndexAU reports. Shareholders of record on Thursday, October 3rd will be paid a dividend of 0.015 per share on Thursday, October 3rd. This represents a yield of 1.91%. The ex-dividend date is Wednesday, September 11th.

The firm’s fifty day moving average price is A$0.90. PM Capital Asian Opportunities Fund has a twelve month low of A$0.81 ($0.57) and a twelve month high of A$1.19 ($0.84).

PM Capital Asian Opportunities Fund Company Profile

PM Capital Asian Opportunities Fund Limited is a closed-ended equity mutual fund launched and managed by PM CAPITAL Limited. It invests in public equity markets of Asia, excluding Japan. The fund seeks to invest in stocks of companies that are operating across diversified sectors. It primarily invests in value stocks of companies.

Featured Story: Example of operating income, EBIT and EBITDA

Receive News & Ratings for PM Capital Asian Opportunities Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PM Capital Asian Opportunities Fund and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nucor  Releases Q3 2019 Earnings Guidance
Nucor Releases Q3 2019 Earnings Guidance
Head-To-Head Review: Jerash Holdings   & Its Competitors
Head-To-Head Review: Jerash Holdings & Its Competitors
Analyzing Provectus Biopharmaceuticals  & Abbott Laboratories
Analyzing Provectus Biopharmaceuticals & Abbott Laboratories
Head to Head Comparison: Cyberark Software  vs. Red Violet
Head to Head Comparison: Cyberark Software vs. Red Violet
Ubiquiti  Cut to Hold at Zacks Investment Research
Ubiquiti Cut to Hold at Zacks Investment Research
Zacks Investment Research Lowers Stellus Capital Investment  to Sell
Zacks Investment Research Lowers Stellus Capital Investment to Sell


 
© 2006-2019 Zolmax.